Voice of the Patient Report Available

We are please to announce that this Rare Disease Day, RhizoKids International has released the official RCDP Voice of the Patient Report. The report is the culmination of RhizoKids International’s Patient-Focused Drug Development session which took place last July. This document is an invaluable resource for educating physicians, other healthcare professionals, drug developers, and the FDA about challenges associated with RCDP and what caregivers are looking for in a treatment for their children.

You can download and review the reports here.